THE EFFECTS OF BICARBONATE AND ACETATE HEMODIALYSIS ON PLATELET CYCLIC-AMP CONCENTRATION, THROMBOXANE B2 RELEASE AND AGGREGATION

被引：2

作者：

TURI, S

BERECZKI, C

TORDAY, C

HAVASS, Z

NEMETH, M

机构：

[1] Department of Paediatrics, Albert Szent-Györgyi Medical University, Szeged

[2] Department of Experimental Surgery, Albert Szent-Györgyi Medical University, Szeged

[3] Department of Clinical Chemistry, Albert Szent-Györgyi Medical University, Szeged

来源：

PEDIATRIC NEPHROLOGY | 1991年 / 5卷 / 03期

关键词：

PLATELET AGGREGATION; CYCLIC AMP; THROMBOXANE B2; UREMIA;

D O I：

10.1007/BF00867493

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The effects of chronic uraemia and serial acetate (HDA) or bicarbonate (HDB) haemodialysis on the aggregation, thromboxane B2 (TXB2) release and cyclic AMP (cAMP) concentration of platelets from arterial blood were studied in 14 uraemic patients (6 dialysed and 8 conservatively treated) and 10 controls. Platelets from uraemic patients, either dialysed or treated conservatively, exhibited a significantly higher cAMP level (P < 0.005), a lower TXB2 level (P < 0.01), and a lower aggregability (P < 0.001) than the controls. The platelet cAMP level was more markedly decreased after HDB than after HDA (P < 0.05). Greater increases in platelet aggregation (P < 0.05) and TXB2 formation were observed after HDB than after HDA. The concentration of platelet cAMP and aggregability, and also the platelet cAMP and the TXB2 level showed a significantly negative correlation (r = -0.7, P < 0.05 and r = -0.60, P < 0.05, respectively). There was a positive correlation between the platelet-derived TXB2 and the aggregability (r = 0.67, P < 0.05). Although most patients had secondary hyperparathyroidism, the serum parathyroid hormone level did not correlate closely with the cAMP, TXB2 or aggregation results. The dysfunction of uraemic platelets accompanied by a reduced TXB2 release may be explained by an increased cAMP and a decreased arachidonic acid availability. HDB improves the platelet function to a greater degree than does HDA.

引用

页码：327 / 331

页数：5

共 32 条

[1]

Larsson S.O., Hedner U., Nilsson I.M., On coagulation and fibrinolysis in conservatively treated chronic uraemia, Acta Med Scand, 189, pp. 433-441, (1971)

[2]

Larsson S.O., Hedner U., Nilsson I.M., On coagulation and fibrinolysis in uraemic patients on maintenance haemodialysis, Acta Med Scand, 189, pp. 443-451, (1971)

[3]

Eknoyan G., Wacksman S.J., Glueck H., Will J.J., Platelet function in renal failure, N Engl J Med, 280, pp. 677-681, (1969)

[4]

Weis H.J., Eichelberger J.W., Secondary thrombocytopathy: platelet factor-3 in various disease states, Arch Intern Med, 47, pp. 901-905, (1968)

[5]

Rabiner S.F., Hrodeck O., Platelet factor-3 in normal subjects and patients with renal failure, J Clin Invest, 47, pp. 901-912, (1968)

[6]

Lewis J.H., Zucker M.B., Ferguson J.H., Bleeding tendency in uraemia, Blood, 11, pp. 1073-1076, (1956)

[7]

O'Grady J.A., Bleeding tendency in uraemia, JAMA, 169, pp. 1727-1732, (1959)

[8]

Remuzzi G., Livio M., Marchiaro G., Mecca G., De Gaetano G., Bleeding in renal failure. Altered platelet function in chronic uraemia only partially corrected by haemodialysis, Nephron, 22, pp. 347-353, (1978)

[9]

Steiner R.W., Coggins C., Carvalho A.C.A., Bleeding time in uraemia: a useful test to assess clinical bleeding, Am J Hematol, 7, pp. 107-117, (1979)

[10]

Lindsay R.M., Friesen M., Koens F., Linton A.L., Oreopulos D., De Veber G., Platelet function in patients on long term peritoneal dialysis, Clin Nephrol, 6, pp. 335-339, (1976)

← 1 2 3 4 →